Patents by Inventor Valérie Tatard

Valérie Tatard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9579287
    Abstract: A method of repairing tissue includes implanting into a patient a therapeutically effective amount of a pharmaceutical composition including microparticles including a biodegradable, biocompatible material having cells of interest or fragments thereof adhered to at least a portion of a surface; and at least one substance active on the cells or their environment upon implantation of the microparticles in a patient associated with the material wherein the substances is released in a controlled or extended manner.
    Type: Grant
    Filed: January 28, 2015
    Date of Patent: February 28, 2017
    Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: Claudia Montero-Menei, Philippe Menei, Jean-Pierre Benoit, Valérie Tatard, Marie-Claire Venier
  • Publication number: 20150174072
    Abstract: A method of repairing tissue includes implanting into a patient a therapeutically effective amount of a pharmaceutical composition including microparticles including a biodegradable, biocompatible material having cells of interest or fragments thereof adhered to at least a portion of a surface; and at least one substance active on the cells or their environment upon implantation of the microparticles in a patient associated with the material wherein the substances is released in a controlled or extended manner.
    Type: Application
    Filed: January 28, 2015
    Publication date: June 25, 2015
    Inventors: Claudia Montero-Menei, Philippe Menei, Jean-Pierre Benoit, Valérie Tatard, Marie-Claire Venier
  • Publication number: 20050129776
    Abstract: Microparticles including a biodegradable, biocompatible material having at least a portion of surface adapted to adhere to cells of interest or fragments thereof; and at least one substance active on the cells or their environment upon implantation of the microparticles in a patient associated with the material wherein the substances is released in a controlled and/or extended manner.
    Type: Application
    Filed: November 3, 2004
    Publication date: June 16, 2005
    Applicant: INSERM
    Inventors: Claudia Montero-Menei, Philippe Menei, Jean-Pierre Benoit, Valerie Tatard, Marie-Claire Venier